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Abstract
Background: SAM68, SAM68-like mammalian protein 1 (SLM-1) and 2 (SLM-2) are members of
the K homology (KH) and STAR (signal transduction activator of RNA metabolism) protein family.
The function of these RNA binding proteins has been difficult to elucidate mainly because of lack
of genetic data providing insights about their physiological RNA targets. In comparison, genetic
studies in mice and C. elegans have provided evidence as to the physiological mRNA targets of
QUAKING and GLD-1 proteins, two other members of the STAR protein family. The GLD-1
binding site is defined as a hexanucleotide sequence (NACUCA) that is found in many, but not all,
physiological GLD-1 mRNA targets. Previously by using Systematic Evolution of Ligands by
EXponential enrichment (SELEX), we defined the QUAKING binding site as a hexanucleotide
sequence with an additional half-site (UAAY). This sequence was identified in QKI mRNA targets
including the mRNAs for myelin basic proteins.
Results: Herein we report using SELEX the identification of the SLM-2 RNA binding site as direct
U(U/A)AA repeats. The bipartite nature of the consensus sequence was essential for SLM-2 high
affinity RNA binding. The identification of a bipartite mRNA binding site for QKI and now SLM-2
prompted us to determine whether SAM68 and GLD-1 also bind bipartite direct repeats. Indeed
SAM68 bound the SLM-2 consensus and required both U(U/A)AA motifs. We also confirmed that
GLD-1 also binds a bipartite RNA sequence in vitro with a short RNA sequence from its tra-2
physiological mRNA target.
Conclusion: These data demonstrate that the STAR proteins QKI, GLD-1, SAM68 and SLM-2
recognize RNA with direct repeats as bipartite motifs. This information should help identify binding
sites within physiological RNA targets.
Background
The K homology (KH domain) is a prevalent RNA binding
domain that is an evolutionarily conserved domain ini-
tially identified as a repeated sequence in the heteronu-
clear ribonucleoprotein particle (hnRNP) K [1]. The KH
domain is a small protein module consisting of 70 to 100
amino acids and it is the second most prevalent RNA
binding domain next to the RRM (RNA recognition
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motif) [2]. The RNA binding property of the KH domain
was initially shown for FMRP, the gene product of the
human fragile X syndrome and hnRNP K [3]. The KH
domain is often found in multiple copies within proteins
(15 in vigilin) and there is a subfamily that contains a sin-
gle copy KH domain that is larger referred to as a maxi-KH
domain [4].
The KH domain makes direct protein-RNA interactions
with a three-dimensional β1α1α2β2β3 topology with an
additional C-terminal α helix (α3) for maxi-KH domains
[1]. The feature of KH domains is an invariant GXXG loop
located between α1/α2 that provides close contact with the
phosphate groups such that the neighboring nucleotides
can form Watson and Crick base pairing with conserved
amino acids within the KH domain [5,6]. The structure
determination of the KH domains has also been solved
with single-stranded DNA, demonstrating that certain KH
domains may accommodate either RNA or ssDNA within
their active site [1,7-9].
There exists a subfamily of KH domains that contain
extended loops between β1/α1 and β2/β3 and that con-
tain an additional C-terminal helix in their topography
[10]. These maxi-KH domain proteins contain conserved
sequences immediately at the N- and C-terminal of the
KH domain. The entire region is referred to as the STAR/
GSG (signal transduction activator of RNA metabolism/
GRP33, SAM68, GLD-1) domain [4,11,12]. Although
STAR proteins contain single KH domains, dimerization is
required for RNA binding [13]. The STAR proteins are
mammalian Sam68, SLM-1, SLM-2, QKI, SF1, C. elegans
GLD-1, Drosophila How, KEP1, Sam50 and Artemia Salina
GRP33 [4]. STAR proteins have been shown to function in
pre-mRNA splicing [14-18], mRNA export [19-21], mRNA
stability [22,23] and protein translation [24-28]. Genetic
evidence has implicated the STAR RNA binding proteins
in many cellular processes. These include the role of the
QKI isoforms in the process of myelination of the central
nervous system [29], GLD-1 in the germline determina-
tion [30-32], How in muscle and tendon differentiation
[4], Kep1 in cell death processes [33] and Sam68 in bone
marrow mesenchymal cell fate [34] and motor defects
[35]. Genetic data has also implicated simple KH domain
proteins FMRP in mental retardation and Nova in parane-
oplastic neurologic disorders [2].
SF1 or branch point binding protein (BBP) was shown to
recognize the branchpoint site RNA sequence (UAC-
UAAC) [6,36] and structure determination has shown
that there is direct protein-RNA contact [6]. These studies
have provided necessary information about the contact
sites of maxi-KH domains and their similarities/differ-
ences with simple KH domains proteins such as Nova.
Based on this information, Ryder and coworkers showed
that GLD-1 binds a hexanucleotide sequence (NACUCA)
and proposed it as the STAR binding site [37]. In a previ-
ous effort by using Systematic Evolution of Ligands by
EXponential enrichment (SELEX) [38], we defined the
QKI RNA binding consensus sequence to be a bipartite
motif consisting of a core NACUAAY (where Y is a pyrimi-
dine) sequence with an neighboring half-site (UAAY)
[39]. In the present study, we define for the first time the
RNA binding specificity of the mammalian STAR protein,
SLM-2. We identified using SELEX the SLM-2 consensus
sequence as a direct U(U/A)AA repeat. The bipartite
nature of the consensus RNA sequence was essential for
high affinity RNA binding activity to SLM-2. The identifi-
cation of a bipartite mRNA binding site for QKI [39] and
now for SLM-2 prompted us to further determine whether
SAM68 and GLD-1 also bound bipartite direct repeats.
Indeed SAM68 and GLD-1 required bipartite RNAs, dem-
onstrating that the STAR proteins SLM-2, SAM68, QKI and
GLD-1 bind direct RNA repeats as a bipartite motif in tar-
get RNAs.
Results
The identification of the SLM-2 RNA binding site by using 
SELEX
To identify the binding motif for the SLM-2 RNA binding
protein, we performed SELEX to enrich for high affinity
RNA ligands. Bacterial recombinant SLM-2 expressed as a
histidine epitope tagged fusion protein was generated and
purified for the assay. Synthetic RNAs were transcribed
with the T7 RNA polymerase from DNA pools of 52-
nucleotide random-mers estimated at a complexity of 1.0
× 1014 and we randomly sequenced 20 RNA molecules
from the initial library and noted, as expected, that each
sequence was unique [39]. The transcribed RNAs were
generated in the presence of 32P-α-UTP such that the
amount of specific SLM-2 bound RNAs could be meas-
ured after each round. After six cycles of selection, we
observed an approximately 10% of binding of the initial
input (not shown), demonstrating that we indeed had
enriched specific sequences. To confirm the SELEX ampli-
fication of the SLM-2 specific RNA ligands, we performed
a gel electromobility shift assays (EMSA) with purified
pools of RNA transcripts isolated from rounds 2, 4 and 6.
The RNAs were 32P-labelled and incubated with buffer or
increasing concentration of His-SLM-2. The SLM-2/RNA
complexes were observed as slow migrating complexes on
native gel electrophoresis (Fig. 1A). More efficient RNA
binding was observed in round 6 than rounds 2 and 4
(compare the free probe remaining from lanes 2 and 6
with lane 10). After round 6, the SLM-2 bound RNAs were
converted into cDNAs, subcloned and sequenced. The
sequence of 43 clones revealed that 11 clones were unique
(Table 1). The clones were referred to as SLM-2 response
element (SRE)-1 to 11. Class I RNAs contained a bipartite
motif consisting of direct repeats of the sequence U(U/BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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A)AA (Table 1). Our data show that the selected RNA
aptamers contained a bipartite motif with direct repeats
and the spacing between the repeats varied from 3 (SRE-
3) to 25 (SRE-7) nucleotides (Table 1 and Fig. 1B). The 3
RNAs identified that did not contain the bipartite
sequence (SRE-9, -10, -11) were grouped in Class II and
since ~10% of RNAs from round 6 bound SLM-2, Class II
RNAs are likely to represent non-binders. No apparent
secondary structure was identified in the SREs using the
prediction of RNA secondary structure program MFOLD
(data not shown). Taken together, we have identified a
bipartite motif consisting of direct repeats of the sequence
U(U/A)AA as the SLM-2 RNA binding site.
A direct repeat of U(U/A)AA defines the SLM-2 RNA 
binding consensus sequence
To define the characteristics of the SLM-2 RNA binding
motif, we performed RNA binding assays with SRE-4 and
SRE-7. We chose SRE-4 and -7 for further analysis because
SRE-4 was the most frequently[40] identified RNA and
SRE-7 contains a guanine-rich sequence at its 5'end in
addition to the UUAA repeats. The 52 mer identified for
SLM-2 RNA ligands identified Figure 1
SLM-2 RNA ligands identified. (A) EMSAs of pooled RNAs identified in rounds 2, 4 and 6 using increasing concentrations of 
His-SLM-2. The protein/RNA complex was separated from the free probe on a native PAGE. The migration patterns of 
unbound RNAs (free probe) and protein bound RNAs (SLM-2/RNA complex) are indicated on the left. (B) The sequences of 8 
unique RNAs bound to SLM-2 after six cycles of SELEX. Both identified motifs are aligned and black undermark. Illustrated, 
underneath the sequences is the probability matrix (graphic logo) based on all the 8 different sequences, depicting the relative 
frequency of each residue at each position within the selected motif.BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
Page 4 of 12
(page number not for citation purposes)
SRE-4 was trimmed to a 38 mer conserving 7 nucleotides
on the 5' and 3' end of the U(U/A)AA consensus sequence
and designated this as SRE-4wt. This synthetic RNA bound
SLM-2 with a high affinity dissociation constant of ~16
nM (Fig. 2A and Table 2) like the 52 mer SRE-4 sequences
(not shown). The substitution of the either or both U(U/
A)AA motifs with CCCC abolished SLM-2 binding (Fig.
2A and Table 2, SRE-4m1, m2, m3). Similarly, the replace-
ment of the UAAA with UACC abolished RNA binding
(SRE-4m4). These finding demonstrate that both tetra-
nucleotide motifs (U(U/A)AA) are required for SLM-2
high affinity RNA binding.
We analyzed SRE-7 and identified a G-rich sequence that
may represent a G quartet. We first proceeded by replacing
the G-rich nucleotides with U-rich sequence and this had
little effect on SLM-2 RNA binding activity (compare SRE-
7m1 and SRE-7wt; Table 2). Interestingly, the replacement
of the G-rich sequences with AU-rich sequences such as to
introduce a third U(U/A)AA motif enhanced SLM-2 RNA
binding to this RNA species (SRE-7m2; Table 2). The sub-
stitution of the downstream uUUAAu sequence with
CGACGC abolished SLM-2 RNA binding consistent with
the U(U/A)AA requirement (SRE-7m2). Numerous 5' and
3' deletions were performed and a minimal sequence of
40 nucleotides was identified containing both U(U/A)AA
motifs that bound with a Kd of ~22.3 nM (SRE-7d9; Table
2). The substitution of the 5' or 3' U(U/A)AA motifs
reduced the SLM-2 high affinity binding site (Table 2;
SRE-7d9m2, m3), demonstrating that indeed SLM-2
binds RNA with high-affinity to direct repeats of U(U/
A)AA.
SAM68 binds the SLM-2 response element
SELEX has been performed with recombinant SAM68 and
a UAAA consensus was defined as a necessary RNA bind-
ing site [41]. As there is 69% sequence identity between
the SLM-2 and SAM68 STAR/GSG domains [42], we tested
the possibility that the SLM-2 consensus (SRE-4) may be
bound by Sam68. Using EMSA with recombinant Sam68
containing only the STAR/GSG domain, we observed that
indeed the GSG domain of SAM68 bound the SRE-4wt
RNA aptamer, but not the variants that contain mutated
U(U/A)AA motifs (Fig. 2B). There was one variant of SRE-
4 (SRE-4m2) that retained some binding and this is likely
due to the polyuridine stretch (UUUU) that remained
between the two U(U/A)AA motifs (Table 2). These find-
ings demonstrate that SAM68 also has the capabilities to
bind a bipartite U(U/A)AA consensus.
Defining the bipartite nature of the QKI response element 
within the mRNAs of myelin basic protein
The mRNAs encoding the myelin basic proteins (MBP) are
known QKI targets [19,43]. The QKI RNA binding site was
defined to be a core (NACUAAC) with a neighboring half-
site (UAAY) [39]. The MBP QREs were defined as QRE-1
and QRE-2 [39,44]. QRE-2 is interesting as it contains two
regions with an overlapping imperfect core (underlined)
and half-site (bold) (UACACACUAAC, QRE-2:wt) as well
as downstream perfect half-site (UAAC) (Fig. 3). Alterna-
tively, region A is recognized as the imperfect half-site
(bold) (UACACACUAAC) and as the perfect core (under-
lined). To define the requirements of QRE-2, we per-
formed EMSA with various combinations of region A and
B. The QRE-2 sequences with regions A and B bound QKI
with high affinity (QRE-2:wt, Kd ~121 nM) and the sub-
stitution of the UAAC half-site in region A or region B
diminished considerably the RNA binding affinity (Fig. 3,
QRE-2:m1, m2). The substitution of the UACA to GAGA
in region A bound with high affinity demonstrating that
region A supplies the perfect core (CACUAGG) and region
B supplies the half-site (UAAC) of the bipartite motif.
These findings demonstrated that region A without region
was unable to serve as a high affinity site for QKI (QRE-
2:m1). Ryder and Williamson showed that region A alone
was bound with high affinity by QKI. We next centered
region A and this considerably improved QKI binding
with a Kd of ~168 nM (Fig. 3, QRE-2:m4). The substitu-
Table 1: Selected SLM-2 bound RNA ligands
Ligand Sequence n
Class I
SRE-1 (1) UUUGGGCCCUUCUAAAGAAAUUUUCACUAUCCUAUUAACAGUUCCGCCGCUC 1
SRE-2 (2) CGUAGGCGCAUCGUUAAAAAUUCAAAGCAAAAAUUGUGUUUAACUGGGGGA- 2
SRE-3 (2) ACGCGCUUUUAACGUGCCCUUACAUCCGCUAAAAACUAAACUCUGACCAUUU 2
SRE-4 (28) UUUGGGGGUUCAAUAAAAAUUUUCACUAUCCUAUUAACAGUUCCGCCGCUCC 28
SRE-5 (1) UUUGGGGGUUCUAUAAAAAUUUUCACUAUCCUAUUAACAGUUCCGCCGCUCC 1
SRE-6 (2) ACAGCACGUUUUAACUUUUUGCUAAUUAUUCCUUAAAAUUCCUCCUCCUCUU 2
SRE-7 (2) AUCGUGGUGGGCGGUUAAUUUGGAUUUCUUGAGCUUAUGGCUUUUAAUAUGG 2
SRE-8 (1) GUGCGAUCUGUGUUUAAUCAUUGUUCUGUUUCGCUCUAAAUUUUUCGCCGCU 1
Class II
SRE-9 (2) GCGGUUACGGGAUCCAUGUAGACGCACAUAUUAUAUGGGAUUAGGUAGACUG 2
SRE-10 (1) GCUGGGGGUUGAUCCACUAUUUCCACAGCGGCAGCAACAGUUCCGCCACUUC 1
SRE-11 (1) AUCGGGGGGGGCGGUUAAUUUGGACUACCCGAGCAUCAGGUCCUCCGCUGGG 1
The UAAA and UUAA conserved motifs are shown in bold. n = number of times identified.BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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Defining the SLM-2 response element as a bipartite RNA sequence Figure 2
Defining the SLM-2 response element as a bipartite RNA sequence. EMSAs with the selected SRE-4 with decreasing 
concentrations of recombinant His-SLM-2 (A) and the SAM68 GSG domain (B) (by a factor of 2 from 1 μM) or with buffer 
alone. The RNA sequence and mutants (m1-m4) used in the reaction are shown in Table 2. Migration patterns of unbound 
RNAs (free probe) and protein bound RNAs (protein-RNA complex) are indicated on the left.BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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tion of either the UAUA to GAGA (QRE-2:m5) or the
UAAC to GAGC (QRE-2:m6) significantly reduced QKI
RNA binding (Fig. 3B). These findings define the QRE-2 as
requiring a bipartite motif located in region A or in region
A plus region B.
GLD-1 binds a bipartite RNA motif containing the 
hexanucleotide
A high affinity RNA binding site has been defined for C.
elegans  GLD-1 that consists of a hexanucleotide
(NACU(C/A)A) [37]. To examine whether the GLD-1 hex-
anucleotide sequence also requires a similar half-site, we
performed EMSA assays with a segment of the tra2 and gli
repeated element (TGE) containing the hexanucleotide
(UACUCAU) and its neighboring half site (UAAU)(Fig.
4A, TGE-wt). GLD-1 bound this wild-type TGE sequence
and a variation of it (TGE-m2) with approximate Kd ~104
nM, defining a short sequence for GLD-1 high affinity
binding (Fig. 4B). These data are consistent with previous
competition experiments that defined the GLD-1 Kd ~10
nM that defined the hexanucleotide as (UACU(C/A)A)
[37]. The nucleotide substitution of the half-site (UAAU
to GAGU) abolished RNA binding (Fig. 4B, TGE-m1),
consistent with the need for a half-site in addition to the
hexanucleotide. Similar binding experiments were per-
formed with QKI and we observed that TGE-m2 is essen-
tially a QRE bound with high affinity, whereas the wild-
type TGE bound with a moderate affinity of approxi-
mately 300 nM (Fig. 4C). The TGE-m1 was not bound by
QKI (Fig. 4C). In summary, these data identify the GLD-1
RNA binding motif as bipartite as observed with SLM-2,
QKI, and Sam68.
Discussion & Conclusion
In the present study, we identified a SLM-2 consensus
sequence as direct U(U/A)AA repeats using SELEX. The
bipartite nature of the consensus sequence was essential
for SLM-2 high affinity RNA binding. The identification of
a bipartite mRNA binding site for QKI [39] and now SLM-
2 prompted us to determine whether SAM68 and GLD-1
also bound bipartite direct repeats. Indeed SAM68 bound
the SLM-2 consensus and required both U(U/A)AA
motifs. Also, GLD-1 required sequences within the UAAY
half-site in addition to its conservative consensus
NACU(C/A)A, defining a GLD-1 bipartite motif. Taken
together, these data demonstrate that the STAR proteins
SLM-2, SAM68, QKI and GLD-1 bind direct RNA repeats.
Defining the SLM-2 RNA binding site as U(U/A)AA repeats
We identified SLM-2 in 1999 by searching databases with
SAM68 sequences [42]. Independently SLM-2 (called T-
STAR) was identified as an interacting protein of RBM, an
RNA binding protein involved in spermatogenesis [45].
SLM-2 is known to bind homopolymeric RNA [42], local-
ize to SAM68 nuclear bodies (SNBs) [46], regulate alterna-
tive splicing [16] and dimerize with SAM68 and SLM-1
[42]. SLM-2 is post-translationally modified to contain
methylarginines [47] and phosphotyrosines, the latter
Table 2: Binding affinity of SLM-2 for selected and mutated RNA ligands
Ligand Sequence Binding affinity
SRE-4wt GGUUCUAUAAAAAUUUUCACUAUCCUAUUAACAGUUCC 16.3 +++
SRE-4m1 GGUUCUAccccAAUUUUCACUAUCCUAccccCAGUUCC >1000 -
SRE-4m2 GGUUCUAccccAAUUUUCACUAUCCUAUUAACAGUUCC >1000 -
SRE-4m3 GGUUCUAUAAAAAUUUUCACUAUCCUAccccCAGUUCC >1000 -
SRE-4m4 GGUUCUAUAcccccUUUCACUAUCCUAUUAACAGUUCC >1000 -
SRE-7wt AUCGUGGUGGGCGGUUAAUUUGGAUUUCUUGAGCUUAUGGCUUUUAAUAUGGG 30.3 +++
SRE-7m1 AUCUUguucucCGCUUAAUUUGGAUUUCUUGAGCUUAUGGCUUUUAAUAUGGG 45.2 +++
SRE-7m2 AUCGUaauaaaCaaUUAAUUUGGAUUUCUUGAGCUUAUGGCUUUUAAUAUGGG 14.5 +++
SRE-7m3 AUCGUGGUGGGCGGUUAAUUUGGAUUUCUUGAGCUUAUGGCUcgacgCAUGGG >1000 -
SRE-7d1 AUCGUGGUGGGCGGUUAAUUUGGAUUU >1000 -
SRE-7d2 GUGGGCGGUUAAUUUGGAUUUCUUGAG >1000 -
SRE-7d3 GGUUAAUUUGGAUUUCUUGAGCUUAUG >1000 -
SRE-7d4 UUUGGAUUUCUUGAGCUUAUGGCUUUU >1000 -
SRE-7d5 UUUCUUGAGCUUAUGGCUUUUAAUAUGG >1000 -
SRE-7d6 GGAUUUCUUGAGCUUAUGGCUUUUAAU >1000 -
SRE-7d7 UAAUUUGGAUUUCUUGAGCUUAUGGCU >1000 -
SRE-7d8 GGUUAAUUUGGAUUUCUUGAGCUUAUGGCUUUU >1000 -
SRE-7d9 GGUUAAUUUGGAUUUCUUGAGCUUAUGGCUUUUAAUAUGG 22.3 +++
SRE-7d9m1 GGUUccccUGGAUUUCUUGAGCUUAUGGCUUUccccAUGG >1000 -
SRE-7d9m2 GGUUccUUUGGAUUUCUUGAGCUUAUGGCUUUUAAUAUGG ≅400 +
SRE-7d9m3 GGUUAAUCUGGAUUUCUUGAGCUUAUGGCUUUUccUAUGG ≅ 400 +
U(U/A)AA motifs are shown in bold and mutated residues are small lettersBMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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Defining the high affinity QRE within the MBPmRNA Figure 3
Defining the high affinity QRE within the MBPmRNA. (A) EMSAs of selected RNAs with increasing concentrations of 
recombinant GST-QKI-5 (by a factor of 2 from 2 nM) or with buffer alone. The RNAs used for the EMSAs are the MBP QRE-
2 and variation mutants of each (m1-m6). Migration patterns of unbound RNAs (free probe) and QKI-5 bound RNAs (QKI-
RNA complex) are indicated on the left. (B) RNA species tested in (A) are shown. The black bars denote sequences that are 
unaltered between the wild-type and the mutant versions.BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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impairs its ability to associate with RNA [48]. The expres-
sion of SLM-2 is mainly restricted to testis and brain, but
its function in these tissues remains unknown [49].
Previously we showed that SLM-2 had a preference for
poly (G) rich homopolymeric RNA [42], therefore, we
searched the SELEX hits for poly (G) rich sequences that
could possibly resemble a G-quartet as bound by FMRP
[50]. The SLM-2 selected RNA (SRE-7) contained a varia-
tion of this sequence (GGnGGGnGGnnnnnnnGG), but
its deletion did not affect SLM-2 RNA binding. Therefore,
we next focused on the U(U/A)AA rich repeats that resem-
ble the consensus identified with SAM68 SELEX [41].
Indeed we mapped the SLM-2 consensus sequence to
direct repeats of the U(U/A)AA sequence, defining a SLM-
2 RNA binding site as a bipartite motif. This motif is too
frequently found in mRNAs especially in 3'-UTR to per-
form a bioinformatic analysis to identify the SLM-2
mRNA targets (not shown). Thus the specificity in SLM-2
function is most likely contributed by its tissue specific
expression and post-translational modifications may alter
its RNA binding specificity and/or accessibility.
Sam68 is known to bind cellular RNA as well as DNA [51].
Sam68 is known to have a preference for poly (U) and
poly (A) homopolymeric RNA and this association is
abrogated with tyrosine phosphorylation by Src kinases
and BRK [52,53]. Differential display and cDNA represen-
tation difference analysis identified 29 potential RNA
binding targets of which 10 bind in a KH-dependent man-
ner [54]. Sam68 binding sequences on hnRNP A2/B1 and
β-actin mRNAs were mapped to UAAA and UUUUUU
nucleotide motifs, respectively and both motifs occur
within specific loop structures [54]. Sam68 has also been
shown to transport unspliced HIV RNAs [20]. The knock-
out Sam68 mice are protected against the development of
osteoporosis pointing towards an enhancement of the
mesenchymal stem cell differentiation along the osteo-
genic rather than the adipocyte pathway [34]. The mice
also have motor coordination defects [35]. The identifica-
tion of Sam68 in these physiological processes will help
direct the search for specific physiological mRNA targets.
The work performed herein demonstrates that the STAR/
GSG domain of Sam68 has similar RNA binding capabil-
ities to SLM-2, as suggested by their 69% sequence iden-
tity within their STAR/GSG domains [42].
QUAKING: a regulator of myelination
The quaking viable (qkv) mice represent an animal model
of dysmyelination [55]. The defect is summarized as an
incomplete maturation of the myelin sheath. This is due
to the lack in proper oligodendrocyte differentiation,
resulting in the failure to transport intracellular myelin
components such as the MBP mRNAs [55]. QKI null ani-
mals have been generated, but the embryos die at ~E9.5–
10.5 day, providing little information about the role of
QKI in myelination [56]. By using a gain-of-function
approach with ectopic expression of the QKI isoforms, we
showed previously that QKI-6 and QKI-7 promote oli-
godendrocyte differentiation by up-regulating p27KIP1,
confirming the role for the QKI isoforms during myelina-
tion [22]. The QKI response element was defined as a core
NACUAAY [44] with a neighboring UAAY [39,44]. This
led to the identification of two binding sites within the
mRNAs for the MBPs [39,44]. QRE-1 contains 3' adjacent
half-sites that function as a moderate affinity site. In the
present study, we demonstrate that region A in QRE-2
(Fig. 4) shown previously to mediate binding [44],
becomes a better site with the presence of the half site
from region B (Fig. 4). Our findings show that QRE-2
within the 3'UTR of MBP mRNAs is indeed a bipartite
consensus sequence with a core NACUAAY and a neigh-
boring UAAY.
The MBP mRNAs are localized at the distal processes of
oligodendrocytes in intact tissue [57]. The factors neces-
sary for MBP mRNA localization are oligodendrocyte-spe-
cific, as transfected MBP mRNA into non-glial cells did
not properly localize to the cell membrane [58]. Studies
GLD-1 binding to the tra2/gli element analysis Figure 4
GLD-1 binding to the tra2/gli element analysis. (A) 
RNA species tested in (B) and (C) are shown. The black bars 
denote sequences that are unaltered between the wild-type 
and the mutant versions. EMSAs of the tra2/Gli element with 
increasing concentrations of GLD-1 (B) and QKI (C) (by a 
factor of 2 from 2 nM) or with buffer alone. Migration pat-
terns of unbound RNAs (free probe) and protein/bound 
RNAs (GLD-1/RNA or QKI/RNA complexes) are indicated 
on the left.BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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performed in living cells by microinjection have shown
that the MBP mRNA forms granules, which appear dis-
persed in the perikaryon and are transported down the
processes [59]. MBP is not the only mRNA known to be
localized to the distal processes of oligodendrocytes, as
myelin oligodendrocytes basic protein (MOBP), alpha-
CAMKII, tau, amyloid precursor protein (APP) and others
are also transported to the site of myelination [60]. Trans-
port and localization elements have been mapped in the
3' UTR of rat and mouse MBP mRNA. A 21-nucleotide
sequence named RNA transport signal (RTS) mapped at
nucleotide 794 to 814 of rat MBP or nucleotide 798 to
818 of mouse MBP has been identified as a transport ele-
ment [61]. This sequence is homologous to several other
localized mRNAs, suggesting a general transport signal. In
rat oligodendrocytes, another localization element has
been mapped to nucleotides 1130 to 1473 named the
RNA localization region (RLR), but the region 667 to 953
containing the RTS and QRE-1 is sufficient for localization
[61]. HnRNP A2 has been shown to be one of the compo-
nent which binds the RTS sequence [62], and insertion of
the RTS into GFP resulted in enhanced translation [63].
The mapping of QRE-2 (UACUAAC-13nt-UAAC) consti-
tutes another element that may be necessary for proper
export of the MBP mRNA into the cytoplasm and subse-
quent production of the MBP at its site of synthesis. It is
likely that QKI works in combination with hnRNP A2 and
the other components of the RNP granule in the proper
transport of the MBP mRNA, its localization and its trans-
lation.
The C. elegans homolog of QKI is GLD-1, a known protein
translation inhibitor required for germ-line differentia-
tion [64,65]. Many GLD-1 mRNA targets have been iden-
tified [25-28] and a conservative consensus sequence of
NACU(C/A)A was defined by comparing the binding spe-
cificity with SF1 [37]. Most, but not all mRNA targets [37],
contain this conversed consensus sequence. The demon-
stration that GLD-1 like QKI requires a neighboring half-
site is consistent with the ~50% sequence identity within
their STAR/GSG domains.
Sam68/SLM-2 tetranucleotide versus QKI/GLD-1 
hexanucleotide sequence requirements
The RNA binding domain of STAR/GSG proteins consist
in a maxi-KH domain flanked by two conserved
sequences (Fig. 5). The NK/QUA1 and CK/QUA2 region
refer to the N- and C-terminal region, respectively, flank-
ing the KH domain. Based on the structure of the KH
domain of SF-1 associated with its binding RNA molecule
U1A2C3U4A5A6C7, the CK region makes important con-
tacts with the RNA. All STAR domain containing proteins
have the most important GXXG sequence located in a
loop between the two first alpha helices of the KH
domain. This sequence of residues is absolutely conserved
among the STAR domain proteins and makes the contact
with the RNA especially with the bases U4A5A6C7. By look-
ing closely at the residues in the CK region that make
important association with the RNA bases, we find that
two residues (asterix on Fig. 5) seems to confer the SLM-
2/SAM68 specificity versus the QKI/GLD-1 specificity. The
SLM-2/SAM68 residues are a threonine or a serine and a
conserved glutamic acid while the QKI/GLD-1/SF1 resi-
dues consist in a conserved alanine and a conserved
arginine. These residues make important contact with
base A2 which specificity is lost in the Slm-2/Sam68 con-
sensus binding sequence. In fact, SLM-2/Sam68 binding
sequence resembles in all points to the QKI/GLD-1/SF1
core binding sequence but lacking U1A2C3 bases.
The STAR protein SF1 structure was determined and the
amino acids that contact the RNA were identified [6].
Based on these contact amino acids, it explains why SF1,
QKI and GLD-1 have near identical binding specificity.
The Sam68, SLM-1 and SLM-2 subfamily have different
amino acids in the RNA contact position and it should be
possible by amino acid substitution to convert a Sam68
domain into a GLD-1 domain that will bind the
NACUA(C/A)C GLD-1 consensus sequence. Lehmann-
Blount & Williamson (2005) have performed such exper-
iments and were unable by mutagenesis to identify an
amino acid 'code' that would dictate GLD-1-like versus
Sam68-like specificity [66]. This led them to propose that
Sam68 and hence SLM-1 and SLM-2 might not be RNA
binding proteins or possess an RNA binding specificity
that is fundamentally unlike that of GLD-1 [66]. The iden-
tification of a high affinity RNA target for SLM-2 with the
characteristics of a GLD-1/QKI bipartite motif, demon-
strates that Sam68, SLM-1 and SLM-2 subfamily are
indeed RNA binding proteins, but does not exclude the
possibility that they may also bind ssDNA. The challenge
ahead will be to identify the physiological RNA targets
linking with the phenotypes observed in mammals.
Methods
SELEX assay
Systematic Evolution of Ligand by EXpornential
enrichement (SELEX) was performed as previously
described [67]. Essentially, an oligonucleotides harboring
a 52-bp random sequence surrounded by two primer
binding sites, with an estimated complexity of 1 × 1015,
were synthesized by (Invitrogen). The oligonucleotides
were amplified by PCR using corresponding forward and
reverse primers as previously described [67]. After PCR
amplification, the sequences of 24 random clones were
determined; each clone was unique and the overall base
composition whoed similarity among the clones (average
composition: A, 20%; U, 30%; C, 22%; G, 28%; data not
shown). A purified DNA library (1 × 1013 molecules) was
transcribed  in vitro using the T7 RNA polymeraseBMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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(Promega) and (α-32P)-UTP. RNA was purified from
denaturing TBE-acrylamide gels, heated to 65°C fro 5
min, and precleared using TALON Metal Affinity Resin
(BD Bioscience) to absorb non-specifically bound RNAs.
Unbound RNAs were incubated in binding buffer (50 mM
Tris-HCl (pH 8.0), 590 mM KCl) with the recombinant
His-SLM-2 for 30 min, then with TALON Metal Affinity
Resin for another 30 min. After four washes with binding
buffer, the RNAs were eluted by TRIzol extraction (Invit-
rogen). The purified RNAs were ethanol precipitated and
resuspended in water with RNase-free DNase for a 15 min
reaction. The DNase reaction was quenched for 10 min at
65°C. Reverse transcriptions were performed using M-
MLV reverse transcriptase (Promega) and a reverse oligo-
nucleotide annealing to the 3' primer binding site. cDNAs
were then generated by PCR amplification with the
reverse oligonucleotide and the forward oligonucleotide
annealing to the 5' primer binding site containing the T7
promoter. After round 6, the cDNAs were amplified with
the reverse primer and a forward primer containing the
STAR/GSG domain protein alignment Figure 5
STAR/GSG domain protein alignment. (A) Diagram representing the structural and functional region of the STAR/GSG 
domain containing proteins. (B) The STAR/GSG domain of mouse SLM-2, human SAM68, mouse QKI, C. elegans GLD-1 and 
human SF-1 were aligned using ClustalW. Secondary structure, beta sheets and alpha helices, are shown on top of the 
sequences and region NK/QUA1, the KH domain and region CK/QUA2 are shown beneath the sequences. The critical loop 
between helices alpha 1 and alpha 2 with the GXXG sequence is also shown. (a) Based on [6] the RNA bases UACUAAC that 
contact with the specific SF-1 residues are numbered as follow U1A2C3U4A5A6C7. (b) Arginine 160 makes contact with U4 and 
A6. (c) Valine 183 makes contact with A6 and C7.BMC Molecular Biology 2009, 10:47 http://www.biomedcentral.com/1471-2199/10/47
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EcoRI restriction site. The DNA fragments were digested
with EcoRI and BamHI and subcloned into pBluescript
SK+ (Stratagene) for blue/white selection. Forty-three ran-
dom white colonies were selected, their plasmid were
purified and the SELEX sequence was identified by DNA
sequencing (Genome Quebec).
RNA preparation, purification and ElectroMobility Shift 
Assays (EMSAs)
RNAs were prepared by run-off in vitro transcription of oli-
gonucleotides harboring a T7 binding site in the presence
of 32P- UTP, using T7 MegaShortscript (Ambion) accord-
ing to the manufacturer's protocols. RNAs were purified
on TBE-acrylamide gels before use. For EMSAs, a constant
concentration of 32P-labeled RNA (100 pmol) was incu-
bated alone with buffer or with increasing or decreasing
concentrations of the corresponding tested proteins in the
following buffer: 20 mM HEPES (pH7.4), 330 mM KCl,
10 mM MgCl2, 0.1 mM EDTA, 0.1 mg/ml heparin and
0.01% IGEPAL CA630 (Sigma). The 30 μl reaction were
incubated at room temperature for 1 h, and 3.3 μl of RNA
loading dye (glycerol containing 0.25% (w/v) bromophe-
nol blue, 0.25% (w/v) xylene cyanol) was added to each.
A portion (15 μl) of each sample was separated on native
Tris-glycine 8%-acrylamide gels. The gels were dried and
the bound and unbound RNAs were quantified using a
Storm Phosphorimager (Amersham). The fraction of
bound RNA was determined and plotted using the soft-
ware program Prism 3.0 (GraphPad Software).
DNA and protein preparation
Recombinant GST-QKI-5 was described previously [39].
Maltose binding protein fused to GLD-1 was a generous
gift of Min-Ho Lee (University of Albany). His-SLM-2 was
prepared from subcloning the coding region from GFP-
SLM-2 [42] into pQE Trisystem (Qiagen) using BamH1
and XhoI directionnal cloning. His-GSG(SAM68) was pre-
pared by subcloning the GSG domain of mouse Sam68
into pET-18c. Protein purification was performed as per
the manufacturer's instructions.
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